GlassScriptPhysician profile
Tonya Allendorfer
NPI 1326657388
$4,909.70
in general payments reported to CMS, 2019-2025
26 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $822 · 2022: $804 · 2023: $2,720 · 2024: $264 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,077 · Travel and Lodging: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.83 |
| Travel and Lodging | $1,207.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,174.60 | 2022-2024 | Bodyguardian, Varithena Administration Pack, Mylux Patient Kit With Mobile Device |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $469.56 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $430.64 | 2021-2025 | |
| Amgen INC. | $296.23 | 2021-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $242.84 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $175.19 | 2021-2024 | Verquvo |
| Pfizer INC. | $171.94 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $134.34 | 2021-2023 | Uptravi, Opsumit |
| Amarin Pharma, INC. | $128.95 | 2021 | |
| Kestra Medical Technology Services, INC. | $108.07 | 2022-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $72.24 | 2022-2023 | Camzyos |
| Tactile Systems Technology INC | $71.29 | 2022-2025 | Nimbl, Flexitouch Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.71 | 2023 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $63.14 | 2021-2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $47.94 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $45.99 | 2025 | Wegovy |
| Cvrx, INC. | $44.86 | 2023-2024 | Barostim Neo System |
| Angiodynamics, INC. | $28.46 | 2023 | Alphavac |
| Philips North America LLC | $22.70 | 2022 | |
| United Therapeutics Corporation | $21.74 | 2023 | Tyvaso |
| Irhythm Technologies, INC. | $20.03 | 2023 | Zio Xt Patch |
| Cardiva Medical, INC. | $19.68 | 2021 | |
| Shockwave Medical, INC | $15.26 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $15.10 | 2022 | |
| Amryt Pharma Holdings LTD | $13.48 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $11.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tonya Allendorfer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.